Apolipoprotein structural organization in high density lipoproteins: Belts, bundles, hinges and hairpins

Current Opinion in Lipidology

Volumn 16, Issue 3, 2005, Pages 295-300

  Davidson, W Sean ^a   Silva, R A Gangani D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I; Apolipoproteins; Discoidal HDL; HDL; Lipid bound; Lipid free; Spherical HDL; Structure; Tertiary structure

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LIPID;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; COMPUTER MODEL; CRYSTAL STRUCTURE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMAGE RECONSTRUCTION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

EID: 20544470749     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000169349.38321.ad     Document Type: Review

References (50)

1. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62:707-714.
2. Asztalos BF, Cupples LA, Demissie S, et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 2004; 24:2181-2187. This paper shows that whereas overall plasma HDL levels are inversely correlated with vascular disease, certain HDL subpopulations may actually correlate positively.
3. Meagher EA. Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: the high-density lipoprotein cholesterol story. Curr Cardiol Rep 2004; 6:457-463.
4. Asztalos BF. High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study. Curr Opin Cardiol 2004; 19:385-391.
5. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968; 9:155-167.
6. Groen AK, Oude Elferink RP, Verkade HJ, Kuipers F. The ins and outs of reverse cholesterol transport. Ann Med 2004; 36:135-145. A solid review of the latest developments in reverse cholesterol transport with a good discussion of the role of the intestine and numerous ABC family transporters.
7. Navab M, Anantharamaiah GM, Reddy ST, et al. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 2004; 109:3215-3220. This work shows the promise of a small amphipathic peptide that can be added to drinking water to modulate the anti-inflammatory nature of HDL as well as stimulate cholesterol efflux. It is an example of how HDL is being specifically targeted for possible coronary artery disease treatment.
8. Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004; 95:764-772. An in-depth summary of an important way in which HDL may protect against coronary artery disease.
9. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [see Comments]. Science 1996; 271:518-520.
10. Brewer HB Jr, Remaley AT, Neufeld EB, et al. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. Arterioscler Thromb Vasc Biol 2004; 10:1755-1760. A good review of the role of ABCA1 in HDL metabolism, with an interesting discussion of how HDL is being taken seriously as a potential treatment strategy.
11. Clark RW, Sutfin TA, Ruggeri RB, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 2004; 24:490-497. This study tests the efficacy of the cholesteryl ester transfer protein inhibitor compound torcetrapib in human subjects. The authors demonstrate a dose-dependent increase in HDL levels. This work has major implications for the protective role of HDL. Is it enough simply to raise HDL levels or is it better to increase cholesterol flux through the system?
12. Toth PP, Davidson MH. Therapeutic interventions targeted at the augmentation of reverse cholesterol transport. Curr Opin Cardiol 2004; 19:374-379.
13. Brouillette CG, Anantharamaiah GM. Structural models of human apolipoprotein A-I [Review]. Biochim Biophys Acta 1995; 1256:103-129.
14. Rye KA, Barter PJ. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004; 24:421-428. A well-written review that focuses on the often neglected subject of the origin of lipid-poor and lipid-free forms of apoA-I.
15. Borhani DW, Rogers DP, Engler JA, Brouillette CG. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci U S A 1997; 94:12291-12296.
16. Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta 2001; 1531:4-46.
17. Wilson C, Wardell MR, Weisgraber KH, et al. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 1991; 252:1817-1822.
18. Wang J, Sykes BD, Ryan RO. Structural basis for the conformational adaptability of apolipophorin III, a helix-bundle exchangeable apolipoprotein. Proc Natl Acad Sci U S A 2002; 99:1188-1193.
19. Gursky O, Atkinson D. Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc Natl Acad Sci U S A 1996; 93:2991-2995.
20. Rogers DP, Roberts LM, Lebowitz J, et al. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry 1998; 37:11714-11725.
21. Saito H, Dhanasekaran P, Nguyen D, et al. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model. J Biol Chem 2003; 278:23227-23232. A careful deletion mutagenesis study demonstrating that lipid-free apoA-I contains a relatively stable domain composed of the N-terminal and central regions and a loosely organized domain in the C-terminus.
22. Saito H, Lund-Katz S, Phillips MC. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog Lipid Res 2004; 43:350-380. A detailed review that extends the concept of a two domain structure in apoA-I and apoE and how this architecture can facilitate lipid binding.
23. Pearson K, Saito H, Woods SC, et al. Structure of human apolipoprotein A-IV: a distinct domain architecture among exchangeable apolipoproteins with potential functional implications. Biochemistry 2004; 43:10719-10729. This work shows that apoA-IV does not exhibit a domain structure that is comparable to apoA-I and apoE. In fact, despite similarities in sequence, apoA-IV seems to be organized quite differently.
24. Fang Y, Gursky O, Atkinson D. Structural studies of N- and C-terminally truncated human apolipoprotein A-I. Biochemistry 2003; 42:6881-6890. This study finds that the N and C-termini are important for maintaining the tertiary structure of lipid-free apoA-I. Furthermore, pH titration studies demonstrate that electrostatic interactions are critical to the solution structure.
25. Zhu HL, Atkinson D. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I. Biochemistry 2004; 43:13156-13164. A study that addresses the structure of the enigmatic N-terminal 44 amino acids of apoA-I and suggests its conformation can change dramatically in response to lipids.
26. Klon AE, Segrest JP, Harvey SC. Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles. Biochemistry 2002; 41:10895-10905.
27. Silva RA, Hilliard GM, Fang J, et al. A three dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry 2005; 44:2759-2769. This study reports one of the first molecularly detailed models of lipid-free apoA-I. The model was generated by combining sequence homology techniques with distance constraints from cross-linking experiments.
28. Segrest JP. Amphipathic helixes and plasma lipoproteins: thermodynamic and geometric considerations. Chem Phys Lipids 1977; 18:7-22.
29. Wald JH, Coormaghtigh E, De Meutter J, et al. Investigation of the lipid domains and apolipoprotein orientation in reconstituted high density lipoproteins by fluorescence and IR methods. J Biol Chem 1990; 265:20044-20050.
30. Jonas A, Kezdy KE, Wald JH. Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J Biol Chem 1989; 264:4818-4824.
31. Koppaka V, Silvestro L, Engler JA, et al. The structure of human lipoprotein A-I. Evidence for the "belt" model. J Biol Chem 1999; 274:14541-14544.
32. Panagotopulos SE, Horace EM, Maiorano JN, Davidson WS. Apoliprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins. J Biol Chem 2001; 276:42965-42970.
33. Narayanaswami V, Maiorano JN, Dhanasekaran P, et al. Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles. J Biol Chem 2004; 279:14273-14279. This study suggests that a belt orientation may be a common theme among the exchangeable apolipoproteins when bound to lipid discs.
34. Segrest JP, Jones MK, Klon AE, et al. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol Chem 1999; 274:31755-31758.
35. Li H, Lyles DS, Thomas MJ, et al. Structural determination of lipid-bound ApoA-I using fluorescence resonance energy transfer. J Biol Chem 2000; 275:37048-37054.
36. Tricerri MA, Behling Agree AK, Sanchez SA, et al. Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: an alternative model based on fluorescence resonance energy transfer experiments. Biochemistry 2001; 40:5065-5074.
37. Davidson WS, Hilliard GM. The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass spectrometry study. J Biol Chem 2003; 278:27199-27207. A cross-linking study that strongly supports the existence of salt bridge interactions proposed for both the double belt and hairpin models.
38. Kunitake ST, Chen GC, Kung SF, et al. Pre-beta high density lipoprotein. Unique disposition of apolipoprotein A-I increases susceptibility to proteolysis. Arteriosclerosis 1990; 10:25-30.
39. Dalton MB, Swaney JB. Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J Biol Chem 1993; 268:19274-19283.
40. Curtiss LK, Bonnet DJ, Rye KA. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Biochemistry 2000; 39:5712-5721.
41. Corsico B, Toledo JD, Garda HA. Evidence for a central apolipoprotein A-I domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles. J Biol Chem 2001; 276:16978-16985.
42. Li L, Chen J, Mishra VK, et al. Double belt structure of discoidal high density lipoproteins: molecular basis for size heterogeneity. J Mol Biol 2004; 343:1293-1311. An interesting study that demonstrates the role of the N-terminal 44 amino acids of apoA-I as a potential hinge domain for modulating HDL particle diameter.
43. Maiorano JN, Jandacek FU, Horace EM, Davidson WS. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size. Biochemistry 2004; 43:11717-11726. This study demonstrates that helices 5, 6 and 7 of apoA-I can move off the edge of an HDL disc as its diameter is changed.
44. Roberts LM, Ray MJ, Shih TW, et al. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I. Biochemistry 1997; 36:7615-7624.
45. Mishra VK, Palgunachari MN, Segrest JP, Anantharamaiah GM. Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis. J Biol Chem 1994; 269:7185-7191.
46. Sparks DL, Phillips MC, Lund-Katz S. The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior. J Biol Chem 1992; 267:25830-25838.
47. Jonas A, Wald JH, Toohill KL, et al. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. J Biol Chem 1990; 265:22123-22129.
48. Saito H, Dhanasekaran P, Nguyen D, et al. Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids. J Biol Chem 2004; 279:20974-20981.
49. Li HH, Lyles DS, Pan W, et al. ApoA-I structure on discs and spheres. Variable helix registry and conformational states. J Biol Chem 2002; 277:39093-39101.
50. Klon AE, Segrest JP, Harvey SC. Molecular dynamics simulations on discoidal HDL particles suggest a mechanism for rotation in the apo A-I belt model. J Mol Biol 2002; 324:703-721.